|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Mar―21 |
Successful use of tofacitinib in reactive arthritis following COVID-19 infection |
Debashis Maikap, Prasanta Padhan |
2 |
[GO] |
2022―Dec―23 |
Abbreviated health-care services for older persons during the COVID-19 pandemic - A wake-up call for a longer-term plan |
Shaileja Yadav, Ashish Goel |
3 |
[GO] |
2022―Oct―24 |
Virtual consultation in lupus during the COVID-19 pandemic - patients' perspective |
Keerthi Talari |
4 |
[GO] |
2022―Oct―06 |
Rituximab and COVID-19 infection in patients with autoimmune rheumatic diseases - A real-world study from India |
John Mathew, AswinM Nair, AS Chandhu, MohammedTanveer Zafar, G Vinodini, Bijesh Yadav, et al. (+2) Shivraj Padiyar, Arvind Ganapati |
5 |
[GO] |
2022―Aug―27 |
Intrauterine onset of multisystem inflammatory syndrome in a neonate temporally associated with maternal COVID-19 |
Shiji Joseph, US Nitya, BrindaM Devassy, AP Anila, Rupesh George, VK Sreenivasan |
6 |
[GO] |
2022―Aug―27 |
COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs |
Vineeta Shobha, ReubenPraharsh Kumar, Sandra Manuel, D Elizabeth |
7 |
[GO] |
2022―Jul―25 |
Impact of COVID-19 on rheumatic diseases in india: Determinants of mortality and adverse outcome: A retrospective, cross-sectional cohort study |
Vineeta Shobha, Avinash Jain, S Chandrashekara, Padmanabha Shenoy, SapanC Pandya, Prakash Chotalia, et al. (+20) Sharath Kumar, Sourabh Malviya, YogeshPreet Singh, Abhishek Patil, Vikas Gupta, Puja Srivastava, VijayaPrasanna Parimi, Chanakya Kodishala, Ramya Janardana, Benzeeta Pinto, Sudhir Bhandari, Govind Rankawat, PraveenPratap Jadhav, Damodaram Potugari, Vishnu Sharma, Alpana Parmar, Sunitha Kayidhi, PaulT Antony, Ashish Badika, Amit Sharma |
8 |
[GO] |
2022―Jul―25 |
Two cases of adult-onset de novo immunoglobulin A vasculitis with nephritis: Post-Covishield (ChAdOx1 nCoV-19; Oxford-Astra Zeneca) vaccination |
VijoyKumar Jha, RamanjitSingh Akal, Debasish Mahapatra, S Harikrishnan, GurpreetKaur Walia |
9 |
[GO] |
2022―Jul―13 |
New-Onset rheumatoid arthritis following ChAdOx1 nCoV-19 vaccine administration |
Bhupen Barman, DebashisPriyadarshan Sahoo, Alvin Khangembam, Muhammad Jamil, Pranav Ish |
10 |
[GO] |
2022―Jun―20 |
Monoclonal antibodies to treat COVID-19 in rheumatoid arthritis: A case report and a clinical appraisal of selected drug trials |
Arvind Chopra |
11 |
[GO] |
2022―Jun―12 |
Granulomatosis with polyangiitis and COVID-19 pneumonia |
Arvind Nune, KarthikeyanP Iyengar, D Mulherin, Pranav Ish, CA Musat, HemRaj Sapkota |
12 |
[GO] |
2022―Jun―12 |
Coronavirus disease 2019 infection and autoimmunity: We see only a tip of the iceberg |
R Naveen |
13 |
[GO] |
2022―Jun―12 |
The emergence of rheumatic immune-mediated inflammatory disease manifestations following SARS-CoV-2 vaccination |
Arvind Nune, HemRaj Sapkota, KarthikeyanP Iyengar |
14 |
[GO] |
2022―Jun―12 |
IgA vasculitis post-ChAdOx1 nCoV-19 vaccine in a patient with rheumatoid arthritis |
Urmila Dhakad, Kunal Chandwar, DigvijayGajanan Ekbote, Juhi Dixit, Kriti Kishor, KiranPreet Malhotra |
15 |
[GO] |
2022―May―21 |
Coronavirus Disease-19 associated arthritis - An observational study |
Sumantro Mondal, Debanjali Sinha, Alakendu Ghosh |
16 |
[GO] |
2022―May―03 |
Anti-synthetase syndrome masquerading as COVID-19 |
Latika Gupta, Rajat Kharbanda, Neeraj Jain |
17 |
[GO] |
2022―May―03 |
Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial |
AryanMohamadfatih Jalal, SheelanFaroz Aref, DashtyAbbas Albustany |
18 |
[GO] |
2022―Apr―20 |
Avascular necrosis - A complication of COVID-19 infection treatment |
YogeshPreet Singh, Pavit Tewatia |
19 |
[GO] |
2022―Apr―04 |
Telerheumatology during the COVID-19 pandemic: Impact on clinical practice, education, and research |
Anastasia-Vasiliki Madenidou, SuAnn Yeoh |
20 |
[GO] |
2022―Apr―04 |
New-onset henoch-Schonlein purpura after COVID-19 vaccination |
RijaMathew Roy, Anna Mani, Joseph John, Thomas Antony, Lydia Jacob |
21 |
[GO] |
2022―Mar―28 |
Hydroxychloroquine in COVID-19 widespread use despite unproven benefit |
Pranav Ish |
22 |
[GO] |
2022―Mar―04 |
Vaccine hesitancy in patients with autoimmune diseases: Data from the coronavirus disease-2019 vaccination in autoimmune diseases study |
Latika Gupta, Parikshit Sen, JamesB Lilleker, Vishwesh Agarwal, Sinan Kardes, Marcin Milchert, et al. (+19) Tamer Gheita, Babur Salim, Tsvetelina Velikova, AbrahamEdgar Gracia-Ramos, Ioannis Parodis, AlbertSelva O'Callaghan, Elena Nikiphorou, AiLyn Tan, Lorenzo Cavagna, MiguelA Saavedra, SamuelKatsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Giovanni Cagnotto, Arvind Nune, Oliver Distler, Hector Chinoy, Rohit Aggarwal |
23 |
[GO] |
2022―Feb―02 |
Humoral responses to SARS-CoV-2 vaccination in rituximab-treated patients depend on peripheral B cell re-population rather than the timings of the dosing |
Padmanabha Shenoy, Rashwith Umesh, Aby Paul, Veena Shenoy, Sakir Ahmed, Somy Cherian, Arya Prasad |
24 |
[GO] |
2021―Nov―26 |
Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases |
Srinivasan Sanjay, Deepika Ponnuru, Sharath Kumar, VijayK R Rao, Ankush Kawali, Padmamalini Mahendradas |
25 |
[GO] |
2021―Oct―28 |
Post corona virus Disease-19 (COVID-19): Hyper inflammatory syndrome-associated bilateral anterior uveitis and multifocal serous retinopathy secondary to steroids |
Srinivasan Sanjay, VijayK R. Rao, Deepashri Mutalik, Padmamalini Mahendradas, Ankush Kawali, Rohit Shetty |
26 |
[GO] |
2021―Oct―28 |
COVID-19 and Rheumatic Diseases in Tamil Nadu - A multicenter retrospective observational study |
Kavitha Mohanasundaram, SowndhariyaV Annamalai, Sham Santhanam, Thilagavathy Nambi, Sriram Sankaran, Raja Natarajan, Prithvi Mohandas |
27 |
[GO] |
2021―Oct―28 |
Recurrent bilateral idiopathic anterior uveitis with vitritis post Coronavirus Disease 2019 infection |
Srinivasan Sanjay, YogeshPreet Singh, Debaditya Roy, Padmamalini Mahendradas, Ankush Kawali, Rohit Shetty |
28 |
[GO] |
2021―Oct―22 |
Hospital outcomes of severe acute respiratory syndrome corona virus 2 in rheumatoid arthritis: A case series observation |
Swathy Moorthy, Sowmya Gopalan, Emmanuel Bhaskar |
29 |
[GO] |
2021―Sep―16 |
COVID-19 anniversary - The hits, the misses, and the way forward: A resident's view |
Kunal Chandwar, Juhi Dixit, Kriti Kishor, DigvijayGajanan Ekbote, Prasanna Dogga |
30 |
[GO] |
2021―Aug―27 |
Spontaneous recovery in a case of lupus with severe COVID-19 pneumonia; Do we need to reconsider treatment Protocol? |
PradeeptaSekhar Patro, Samir Sahu, Shawaz Iqbal, IshwarChandra Behera, Priyanka Samal, Satyasundar Mohapatra |
31 |
[GO] |
2021―Jun―25 |
Psychological impact of coronavirus disease 2019 pandemic on patients with rheumatological disorders: A web-based cross-sectional multicentric survey |
GC Yathish, YogeshPreet Singh, Shiva Prasad, Nagaraj Srinivasulu, Sharath Kumar, R Subramanian, et al. (+4) Pramod Chebbi, Vikramraj Jain, Naman Jain, Satish Kumar |
32 |
[GO] |
2021―May―08 |
Utility of hydroxychloroquine for COVID-19: Are we hoping against hope? |
Latika Gupta, KC Manish, Shailesh Advani |
33 |
[GO] |
2021―Apr―12 |
Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic |
Anupam Wakhlu, Manesh Manoj, Prashant Bafna, RasmiRanjan Sahoo, Kasturi Hazarika |
34 |
[GO] |
2021―Apr―12 |
Virtual consulting for remote physiotherapy advice in chronic rheumatic diseases during the COVID-19 pandemic |
IlkeCoskun Benlidayi |
35 |
[GO] |
2021―Apr―12 |
Coping with the Coronavirus Disease-2019 pandemic: A giant leap towards digital transformation in academic research |
Latika Gupta, SalikaFakirmahmad Gadiwala |
36 |
[GO] |
2021―Mar―04 |
Virtual consulting in the times of COVID-19 |
Latika Gupta, Supriya Sharma, Rajat Kharbanda, Shelley Aggarwal, DurgaPrasanna Misra, Vikas Agarwal |
37 |
[GO] |
2021―Mar―04 |
COVID-19 and osteoarticular tuberculosis: Challenges and perspectives from a developing nation |
Pranav Ish, KarthikeyanP Iyengar, Anil Agarwal, VijayKumar Jain |
38 |
[GO] |
2021―Mar―04 |
Telecommunication in the COVID-19 era: As an assessment tool for patients with dermatomyositis |
Latika Gupta, Prakash Gupta |
39 |
[GO] |
2021―Mar―04 |
Treatment adherence and disease status among children with rheumatological diseases during COVID-19 pandemic: A cross-sectional study from a tertiary care center |
Sabarinath Mahadevan, Balakrishnan Navaneethan, GS Nikhila, S Sreenath, M Mahabaleshwar, S Vishnupriya, et al. (+2) TN Tamilselvam, NPonnien Selvan |
40 |
[GO] |
2021―Feb―16 |
Hyperinflammatory syndrome in children related to Covid-19 |
Latika Gupta, TG Sundaram |
41 |
[GO] |
2020―Oct―21 |
Pneumonia complicated by SARS-coV-2 infection in three patients with ankylosing spondylitis who are on anti-TNF therapy: Case-based review |
Serdar Kaymaz, Ugur Karasu, Veli Çobankara, Hakan Alkan, Firdevs Ulutas |
42 |
[GO] |
2020―Oct―13 |
Knowledge on hydroxychloroquine prescription and attitude toward its use in COVID-19 - A survey-based study among doctors |
TMuhammed Razmi, TP Afra, NA Uvais, Anuradha Bishnoi, Edavalath Sukesh, Salin Eliyas, NA Bishurul Hafi |
43 |
[GO] |
2020―Oct―13 |
Impact of COVID-19 Pandemic and Resultant Lockdown in India on Patients with Chronic Rheumatic Diseases: An Online Survey |
John Mathew, Arvind Ganapati, Shivraj Padiyar, Aiswarya Nair, Mahasampath Gowri, Upasana Kachroo, et al. (+2) AswinM Nair, Sangeetha Priya |
44 |
[GO] |
2020―Oct―06 |
Arthritis as a distinctive atypical clinical presentation of COVID-19 |
Anjana Pandey, Prabhat Agrawal, Ruchika Garg, Ashish Gautam |
45 |
[GO] |
2020―Jun―08 |
Convalescent plasma therapy in severe coronavirus disease-2019: A narrative review |
Anupam Wakhlu, RasmiRanjan Sahoo, Kasturi Hazarika, Prashant Bafna, Manesh Manoj |
46 |
[GO] |
2020―May―29 |
COVID-19: An update on vaccine development |
Deepak Tripathi, Guohua Yi, Ramakrishna Vankayalapati |
47 |
[GO] |
2020―Apr―14 |
Coronavirus disease-19 and rheumatological disorders: A narrative review |
Aman Sharma, Arghya Chattopadhyay, Debashish Mishra, Vikas Sharma, GSRSN K Naidu |
48 |
[GO] |
2020―Apr―07 |
Interleukin-6 and other cytokine blockade in COVID-19 hyperinflammation |
AthimalaipetV Ramanan, Latika Gupta, Vikas Agarwal |
49 |
[GO] |
2020―Mar―28 |
To Act…….or to wait for the evidence: Ethics in the time of covid-19! |
Vikas Agarwal, DurgaPrasanna Misra |